A. Leber et al., THE YEAST MIC2 MUTANT IS DEFECTIVE IN THE FORMATION OF MANNOSYL-DIINOSITOLPHOSPHORYLCERAMIDE, FEBS letters, 411(2-3), 1997, pp. 211-214
The mic2 mutation dominantly blocks formation of mannosyl-diinositolph
osphorylceramide, the most abundant sphingolipid of the yeast, Sacchar
omyces cerevisiae, Interestingly, lack of mannosyl-diinositolphosphory
lceramide is not lethal but is compensated for by increased amounts of
inositolphosphorylceramide and mannosyl-inositolphosphorylceramide in
the plasma membrane and Golgi of the mutant. The level of negatively
charged phospholipids in the plasma membrane of the mid strain is mark
edly reduced; the sterol composition is not altered, In spite of drama
tic changes of its lipid composition the mutant grows like wild type o
n complex and minimal media, under osmotic stress conditions, at low p
H, and in the presence of high ionic strength. While sensitivity to se
veral drugs is not altered, the mic2 mutant strain becomes resistant t
o the polyene antibiotic nystatin. (C) 1997 Federation of European Bio
chemical Societies.